ARCHIVES

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

CCOP Pink Sheets Go Out, Details Starting to Emerge On Number Of Awards, Payline, Possible Exceptions

May 6, 1983

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

ASCO Recommends End of Life Discussions

January 28, 2011